Recent decisions at the FDA threaten to turn its disagreements with the drugmaker UniQure into another political headache for ...
Vinay Prasad, a top official at the Food and Drug Administration who has been at the center of recurring public controversies, is exiting the agency for a second time. Prasad will leave the FDA at the ...
A federal appeals court will hear arguments Friday in the Trump administration's effort to subpoena patient records on gender ...
Trump wants to focus on his efforts to lower drug prices, but the TrumpRx website is falling short of his promises.
For many religious objectors, including Amish, vaccination rejection is a situational interpretation of religious doctrine, ...
Stand Up For Science has become a formal organization and adopted a new strategy that's more confrontational with grassroots ...
Meanwhile, Moderna is trying to reset its future around oncology.
In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.
China has approved a new obesity treatment from Pfizer, heightening competition in a market poised to become even more crowded ...
Science Corp. raised $230 million as it awaits a decision from the FDA on PRIMA, its wireless retinal implant.
Immediately after U.S. health officials linked Tylenol to autism, the drug's use in pregnant women visiting ERs dropped, new ...
Servier said it would buy Day One Biopharmaceuticals, the maker of a drug for childhood brain tumors, in a deal worth roughly $2.5 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results